NOS3 and diabetic kidney disease: For example, enhanced glucose metabolism in the hexosamine pathway increased O-linked β-N-acetylglucosamine (O-GlcNAc) modification of endothelial nitric oxide synthase (eNOS) in experimental DKD and subsequent ROS production (Du et al., 2001).